Cash Flow Statement

Amortization Amortization Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Working Capital Change in Working Capital Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Growth Metrics

Others

Avricore Health (AVCRF) Cash from Discontinued Operations (2019)

Avricore Health has reported Cash from Discontinued Operations over the past 1 years, most recently at 58325.1 for Q4 2019.

Quarterly Cash from Discontinued Operations changed N/A to 58325.1 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was 131179.81 through Dec 2019, changed N/A year-over-year, with the annual reading at 133264.41 for FY2019, 155.99% up from the prior year.
Cash from Discontinued Operations was 58325.1 for Q4 2019 at Avricore Health, down from 11415.19 in the prior quarter.
Over five years, Cash from Discontinued Operations peaked at 125881.08 in Q2 2019 and troughed at 58325.1 in Q4 2019.